The Karnataka Bioeconomy Report 2025, released by the state's IT/BT ministry, in collaboration with the Association of Biotechnology Led En...

Under the BioE3 Policy, 21 bioenablers will drive advanced biomanufacturing, reduce reliance on imports, generate employment, and position ...

India has launched a network of advanced biomanufacturing hubs to boost its bioeconomy and drive innovation across sectors like health, agr...

In 2024, South India led India's bioeconomy, contributing 45.4% ($75.2 billion), with Maharashtra, Karnataka, and Telangana emerging as key...

In 2024, India's biopharma sector marked notable achievements, with approvals of key biosimilars and the launch of advanced CAR-T therapy. ...

Assam Chief Minister Himanta Biswa Sarma has proposed several initiatives to enhance scientific and technological innovation, and local ind...

India's BioE3 policy is set to revolutionize biotech research with AI-powered bio-foundries. These hubs will speed up experiments and valid...

The government's Bio-E3 policy aims to position India as a global bio-economy leader, similar to the IT revolution in the West. Launched la...

Union Minister Jitendra Singh highlighted that bio-manufacturing is set to revolutionize the global economy, with India poised to lead due ...

The Union Cabinet has approved the Biotechnology for Economy, Environment, and Employment (BioE3) policy. This initiative aims to enhance r...

In her last budget speech before general elections, finance minister Nirmala Sitharaman has presented an all-encompassing, growth-focused f...

Information and biotechnology minister Priyank Kharge said the new biotechnology policy would synergize with the others in the state, inclu...

The Minister said the Eastern Himalayan Region is one of the mega-biodiversity rich zones and is among the 34 biodiversity Hotspots of the ...

"India's Bio-Economy is on way to achieve 150-billion-dollar target from the current 70 billion-dollar to contribute effectively to the Pri...

Addressing a webinar titled 'Global Perspective on India's Biotech Potential: Manufacturing Hub & Foreign Investment', Kant said India is w...

The PM highlighted the need for ‘Make in India’ initiatives in medical devices so that people benefit from the fruits of advances in diagno...

India is facing a severe shortage of people with specialised skills for developing new drugs and may try to rope in consultants of local or...